valine and cyclohexanol

valine has been researched along with cyclohexanol in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	7 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hopkins, SC; Koblan, KS; Reasner, DS	1
Ahad, A; Ali, A; Aqil, M	1
Ahad, A; Aqil, M; Kohli, K; Mujeeb, M; Sultana, Y	1
Alqarni, M; Bartlow, P; Feng, R; Myint, KZ; Tong, Q; Wang, L; Xie, XQ; Yang, P	1
Hodges, MR; Ottosen, S; Parsley, TB; Patick, AK; Raney, AK; van der Veer, E; van Doorn, LJ; Yang, L; Zeh, K	1
Banister, SD; Connor, M; Glass, M; Kassiou, M; Kevin, R; Longworth, M; Mack, JB; McGregor, IS; Sachdev, S; Santiago, M; Stuart, J	1
Glass, M; Lefever, TW; Thomas, BF; Wiley, JL	1

Trials

2 trial(s) available for valine and cyclohexanol

Article	Year
Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder. Psychiatry research, 2013, Aug-15, Volume: 208, Issue:3 Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Catechol O-Methyltransferase; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Genotype; Humans; Male; Methionine; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Psychiatric Status Rating Scales; Time Factors; Valine; Venlafaxine Hydrochloride; Young Adult	2013
In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: 5' Untranslated Regions; Antiviral Agents; Carbamates; Cyclohexanols; Drug Resistance, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Macrocyclic Compounds; MicroRNAs; Molecular Targeted Therapy; Mutation; Oligonucleotides; Oligopeptides; Pyrrolidines; Quinolines; Replicon; Thiazoles; Thiophenes; Valine	2015

Article

Year

Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder.

Psychiatry research, 2013, Aug-15, Volume: 208, Issue:3

Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Catechol O-Methyltransferase; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Genotype; Humans; Male; Methionine; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Psychiatric Status Rating Scales; Time Factors; Valine; Venlafaxine Hydrochloride; Young Adult

2013

In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122.

Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

Topics: 5' Untranslated Regions; Antiviral Agents; Carbamates; Cyclohexanols; Drug Resistance, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Macrocyclic Compounds; MicroRNAs; Molecular Targeted Therapy; Mutation; Oligonucleotides; Oligopeptides; Pyrrolidines; Quinolines; Replicon; Thiazoles; Thiophenes; Valine

2015

Other Studies

5 other study(ies) available for valine and cyclohexanol

Article	Year
Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole. International journal of biological macromolecules, 2014, Volume: 64 Topics: Acrylic Resins; Administration, Cutaneous; Animals; Antihypertensive Agents; Blood Pressure; Chemistry, Pharmaceutical; Cyclohexanols; Disease Models, Animal; Eucalyptol; Gels; Monoterpenes; Rats; Skin; Tetrazoles; Valine; Valsartan	2014
Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats. Expert opinion on drug delivery, 2014, Volume: 11, Issue:8 Topics: Administration, Cutaneous; Angiotensin II Type 1 Receptor Blockers; Animals; Biological Availability; Chemistry, Pharmaceutical; Cyclohexanols; Drug Compounding; Drug Delivery Systems; Eucalyptol; Gels; Humans; Monoterpenes; Rats; Rats, Wistar; Skin; Skin Absorption; Solvents; Tetrazoles; Valine; Valsartan; Viscosity	2014
Examining the critical roles of human CB2 receptor residues Valine 3.32 (113) and Leucine 5.41 (192) in ligand recognition and downstream signaling activities. Biochemical and biophysical research communications, 2014, Sep-26, Volume: 452, Issue:3 Topics: Animals; Binding Sites; Camphanes; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; CHO Cells; Cricetulus; Cyclic AMP; Cyclohexanols; Escherichia coli; Humans; Hydrophobic and Hydrophilic Interactions; Leucine; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Protein Binding; Pyrazoles; Receptor, Cannabinoid, CB2; Recombinant Proteins; Signal Transduction; Valine	2014
Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues. ACS chemical neuroscience, 2016, 09-21, Volume: 7, Issue:9 Topics: Analgesics; Animals; Body Temperature; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Heart Rate; Humans; Indazoles; Indoles; Leucine; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Valine	2016
Do you feel it now? Route of administration and Δ Neurotoxicology, 2019, Volume: 73 Topics: Administration, Inhalation; Aerosols; Animals; Behavior, Animal; Cannabinoids; Conditioning, Operant; Cyclohexanols; Electronic Nicotine Delivery Systems; Female; Indazoles; Injections, Intraperitoneal; Male; Mice, Inbred C57BL; Valine; Vaping	2019